Showing results (1401-1410 of 1,449) with videos related to

Sort By:
Pageof 145
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Divergent landscapes of A-to-I editing in postmortem and living human brainMiguel Rodriguez de Los Santos, Brian H Kopell, Ariela Buxbaum Grice, et al.
JAMA Network Open|May 1, 2024
Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided RadiotherapyJasmijn M Westerhoff, Lois A Daamen, John P Christodouleas, et al.
Nature Medicine|December 18, 2020
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trialKatie J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer, et al.
NEJM Evidence|May 19, 2023
Covid-19 Rates by Time since Vaccination during Delta Variant PredominanceGabriela Paz-Bailey, Maya Sternberg, Kiersten Kugeler, et al.
The Journal of Infectious Diseases|February 25, 2016
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01Ruth O Payne, Kathryn H Milne, Sean C Elias, et al.
Cell|July 26, 2024
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotypeJordan R Barrett, Dimitra Pipini, Nathan D Wright, et al.
Nature Communications|June 17, 2021
The long lives of primates and the 'invariant rate of ageing' hypothesisFernando Colchero, José Manuel Aburto, Elizabeth A Archie, et al.
Nature Communications|September 25, 2025
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infectionMimi M Hou, Adam C Harding, Natalie M Barber, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) ConsortiumIsabel K Schuurmans, Rosa H Mulder, Vilte Baltramonaityte, et al.
The Lancet. Infectious Diseases|June 16, 2024
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trialSarah E Silk, Wilmina F Kalinga, Jo Salkeld, et al.
Pageof 145